Differences in the Evolution of Lung Function Before and After Treatment With Antifibrotics in Patients With Interstitial Lung Disease

Differences in the Evolution of Lung Function Before and After Treatment With Antifibrotics in Patients With Interstitial Lung Disease

Bibliographic Details
Main Authors:	Katiuska Herminia Liendo-Martínez, Francisco Javier Baratech-Calpena, Zichen Ji, Fernando Pedraza-Serrano, Francisco José Caballero-Segura, Javier de Miguel-Díez
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	Open Respiratory Archives
Online Access:	http://www.sciencedirect.com/science/article/pii/S2659663623000541

Similar Items

Antifibrotic therapies in rheumatoid arthritis associated interstitial lung disease
by: Cemal Bes, et al.
Published: (2022-07-01)

Antifibrotic in interstitial lung diseases: When, where, and how long?
by: Deependra K Rai, et al.
Published: (2022-01-01)

Interstitial lung diseases: the role of HRCT in in the era of antifibrotic therapy
by: Alfredo Nicodemos Cruz Santana, et al.
Published: (2020-11-01)

The role of antifibrotics in the treatment of rheumatoid arthritis–associated interstitial lung disease
by: Minrui Liang, et al.
Published: (2022-02-01)

Pleuroparenchymal Fibroelastosis. Is it Really Uncommon? Report of Eight Cases
by: Stephany Ivonne Briones Alvarado, et al.
Published: (2024-01-01)

Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease
by: Erin M. Wilfong, et al.
Published: (2021-12-01)

Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD
by: John N. Shumar, et al.
Published: (2021-05-01)

Use of a pulmosphere model to evaluate drug antifibrotic responses in interstitial lung diseases
by: Kevin G. Dsouza, et al.
Published: (2023-03-01)

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease
by: Atsushi Kumanogoh, et al.
Published: (2023-01-01)

Antifibrotic Agents in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis
by: Ji Hoon Jang, et al.
Published: (2023-12-01)

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
by: Sebastiano Emanuele Torrisi, et al.
Published: (2019-11-01)

Impact of Antifibrotic Treatment on Postoperative Complications in Patients with Interstitial Lung Diseases Undergoing Lung Transplantation: A Systematic Review and Meta-Analysis
by: Pahnwat Taweesedt, et al.
Published: (2023-01-01)

A multicenter survey study of antifibrotic use for symptomatic patients with post-COVID-19 interstitial lung abnormalities
by: Sahajal Dhooria, et al.
Published: (2022-01-01)

Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications
by: Gian Luca Erre, et al.
Published: (2021-01-01)

Evaluation of the potential complication of interstitial lung disease associated with antifibrotic drugs using data from databases reporting spontaneous adverse effects
by: Hideki Nawa, et al.
Published: (2022-12-01)

COVID-19-Associated Lung Fibrosis: Two Pathways and Two Phenotypes, Lung Transplantation, and Antifibrotics
by: René Hage, et al.
Published: (2022-07-01)

Lung transplantation for interstitial lung disease: evolution over three decades
by: Gerard Meachery, et al.
Published: (2023-11-01)

Use of antifibrotic drugs in familial interstitial pneumonia: analysis of one family
by: Deborah dos Reis Estrella, et al.
Published: (2021-12-01)

Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia
by: Keishi Sugino, et al.
Published: (2021-03-01)

Pleiotropic antifibrotic actions of aspirin-triggered resolvin D1 in the lungs
by: Rafael F. Guilherme, et al.
Published: (2023-03-01)

Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
by: Bridget F. Collins, et al.
Published: (2019-10-01)

Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
by: Sachin Chaudhary, et al.
Published: (2020-09-01)

Erratum: Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group
Published: (2022-01-01)

Enfermedad de Erdheim-Chester: dificultades en el diagnóstico y tratamiento
by: Marta Fuentes Alonso, et al.
Published: (2021-01-01)

Corrigendum: Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
by: Sachin Chaudhary, et al.
Published: (2021-03-01)

Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
by: Hiroshi Takahashi, et al.
Published: (2021-08-01)

Commentary: Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
by: Soroush Seifirad, et al.
Published: (2021-01-01)

Lung transplantation for interstitial lung disease
by: Siddhartha G. Kapnadak, et al.
Published: (2021-08-01)

Interstitial lung disease
by: Vincent Cottin
Published: (2013-03-01)

Interstitial lung disease
by: Katerina M. Antoniou, et al.
Published: (2014-03-01)

Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality
by: Qian Zhou, et al.
Published: (2023-03-01)

The detection, assessment and clinical evolution of interstitial lung abnormalities identified through lung cancer screening
by: Haval Balata, et al.
Published: (2023-05-01)

Lung Ultrasound in Diagnosis of Interstitial Lung Disease
by: Sagun Manandhar
Published: (2023-07-01)

In Vitro and In Vivo Antifibrotic Effects of Fraxetin on Renal Interstitial Fibrosis via the ERK Signaling Pathway
by: Yi-Hsien Hsieh, et al.
Published: (2021-07-01)

HGF Expressing Stem Cells in Usual Interstitial Pneumonia Originate from the Bone Marrow and Are Antifibrotic.
by: Amiq Gazdhar, et al.
Published: (2013-01-01)

A new antifibrotic target of Ac-SDKP: inhibition of myofibroblast differentiation in rat lung with silicosis.
by: Hong Xu, et al.
Published: (2012-01-01)

Antifibrotics in India
by: Raja Dhar
Published: (2019-01-01)

Interstitial Lung Disease Associated with Lung Cancer Treatment
by: Zhiwei CAO, et al.
Published: (2013-05-01)

Telomeres in Interstitial Lung Disease
by: Carmel J. W. Stock, et al.
Published: (2021-03-01)

Oxygen in interstitial lung diseases
by: Ricardo Cordeiro, et al.
Published: (2023-03-01)